| Name | Title | Contact Details |
|---|
National HME is accredited by HQAA for Hospice Medical Equipment Services, as well as Clinical Respiratory Services. * National HME provides equipment for hospice patients 24/7 at no additional cost to the hospice program. * National HME provides simplified billing allowing your program more time to devote to patient care while reducing the hassle of HME bill reconciliation. Most contracts offered to hospice programs promote all-inclusive packaging with minimal extra charges allowing you the peace of mind that comes with understanding the exact cost for HME. * National HME maintains a minimal amount of warehoused equipment to streamline and work efficiently in our distribution centers. With new contracts equipment will be purchased for your initial deliveries and start up. This will bring a sense of revitalization to your staff and patients, enhancing morale and improving referrals. * Our staff at National HME are specifically trained to understand the process of the hospice industry; including death and dying, dealing with emotional and difficult family situations while showing compassion and empathy. We have extensive competency requirements for every employee that works at National HME. * Training for the family and care givers is extensive including detailed written materials provided. * We utilize modern technology that allows for web based ordering, a paperless delivery system that provides real time delivery and better control of the assets of the company. In the near future, we expect our equipment to have RFID technology that will allow us to find misplaced items in facilities more efficiently.
Saratoga Ventures LP is a Saratoga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A-Med Home Health is a Texas City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Agde Corp. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The world`s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, Bolon™ and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs 64,000 people worldwide. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as five research and development centers around the world.